Nanomedicine in Targeted Drug Delivery: Precision Therapeutics for Personalized Medicine

In the ongoing quest to improve treatment effectiveness while reducing negative side effects, nanomedicine has risen as a groundbreaking frontier in the realm of healthcare. This chapter elaborates on the growing field of nanotechnology applied to targeted drug delivery, revealing its pivotal role in revolutionizing precision therapeutics for personalized medicine. At its core, nanomedicine harnesses nanoscale materials as carriers to transport therapeutic payloads to designated cellular targets precisely. This approach mitigates systemic exposure, minimizing off-target effects and bolstering the therapeutic index of drugs. The chapter explores a diverse array of nanocarriers, including liposomes, polymeric nanoparticles, dendrimers, and exosomes, delineating their distinct advantages and applications in targeted delivery. The key discussion of this chapter is the intricate interplay between nanocarrier design and targeting strategies, elucidating how surface modifications, ligand conjugation, and stimuli-responsive systems enable precise localization and controlled release of therapeutic agents. Case studies across oncology, neurology, infectious diseases, and beyond underscore the transformative impact of nanomedicine in tailoring treatments to individual patients, culminating in the paradigm of personalized medicine. Moreover, the chapter outlines the challenges and prospects in translating these innovations from bench to bedside, addressing considerations such as scalability, biocompatibility, and regulatory hurdles. It also anticipates future directions, including the integration of diagnostics with therapeutics, and theranostic platforms in optimizing personalized nanomedicine.